The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution
[...]an additional dimension has been added to the CKD staging system. Looking ahead, we predict a future when a more sophisticated classification emerges-perhaps underpinned by molecular diagnostics-in which cys- tatin C and other markers are used more widely to re- fine our measurement of GFR, oth...
Gespeichert in:
Veröffentlicht in: | Clinical chemistry (Baltimore, Md.) Md.), 2013-03, Vol.59 (3), p.462-465 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [...]an additional dimension has been added to the CKD staging system. Looking ahead, we predict a future when a more sophisticated classification emerges-perhaps underpinned by molecular diagnostics-in which cys- tatin C and other markers are used more widely to re- fine our measurement of GFR, other specific urinary markers are used to assess kidney damage, an accurate determination of cause completes a multidimensional picture of an individual CKD patient, and clinical lab- oratories may use routine tests to compute and report prognosis. |
---|---|
ISSN: | 0009-9147 1530-8561 |
DOI: | 10.1373/clinchem.2012.184259 |